Radiation-induced lymphopenia and the survival of women with cervical cancer: a meta-analysis

References

• Cesaire, M., et al., 2020. [Mechanisms of radiation-induced lymphopenia and therapeutic impact]. Bulletin du Cancer, 107 (7-8), 813–822.
   PubMed Web of Science ®Google Scholar
• Chargari, C., et al., 2022. Radiotherapy of cervical cancer. Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie Oncologique, 26 (1-2), 298–308.
   PubMed Web of Science ®Google Scholar
• Chen, L., et al., 2015. Decreased pretreatment lymphocyte/monocyte ratio is associated with poor prognosis in stage Ib1-IIa cervical cancer patients who undergo radical surgery. OncoTargets and Therapy, 8, 1355–1362.
   PubMed Web of Science ®Google Scholar
• Cho, O., Chun, M. and Chang, S.J., 2022. Exponential slope from absolute lymphocyte counts during radio-chemotherapy can predict an aggressive course of cervical cancer. Cancers, 14, 5109.
   PubMed Web of Science ®Google Scholar
• Cho, O., et al., 2016. Prognostic value of severe lymphopenia during pelvic concurrent chemoradiotherapy in cervical cancer. Anticancer Research, 36 (7), 3541–3547.
   PubMed Web of Science ®Google Scholar
• Cohen, P.A., et al., 2019. Cervical cancer. Lancet, 393 (10167), 169–182.
   PubMed Web of Science ®Google Scholar
• Damen, P.J.J., et al., 2021. The influence of severe radiation-induced lymphopenia on overall survival in solid tumors: a systematic review and meta-analysis. International Journal of Radiation Oncology, Biology, Physics, 111 (4), 936–948.
   PubMed Web of Science ®Google Scholar
• Dessole, M., et al., 2018. Quality of life in women after pelvic exenteration for gynecological malignancies: a multicentric study. International Journal of Gynecological Cancer, 28 (2), 267–273.
   PubMed Web of Science ®Google Scholar
• Egger, M., et al., 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ, 315 (7109), 629–634.
   PubMed Web of Science ®Google Scholar
• El Houat, Y., et al., 2023. Meta-analysis and critical review: association between radio-induced lymphopenia and overall survival in solid cancers. Advances in Radiation Oncology, 8 (2), 101038.
   PubMedGoogle Scholar
• Fagotti, A., et al., 2016. Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. European Journal of Cancer, 59, 22–33.
   PubMed Web of Science ®Google Scholar
• Higgins, J., et al., 2021. Cochrane Handbook for Systematic Reviews of Interventions version 6.2. The Cochrane Collaboration. www.training.cochrane.org/handbook
   Google Scholar
• Higgins, J.P. and Thompson, S.G., 2002. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21 (11), 1539–1558.
   PubMed Web of Science ®Google Scholar
• Holub, K., Vargas, A. and Biete, A., 2020. Radiation-induced lymphopenia: the main aspects to consider in immunotherapy trials for endometrial and cervical cancer patients. Clinical & Translational Oncology, 22 (11), 2040–2048.
   PubMed Web of Science ®Google Scholar
• Lagana, A.S., et al., 2021. Vaginal stenosis after cervical cancer treatments: challenges for reconstructive surgery. Journal of Investigative Surgery: The Official Journal of the Academy of Surgical Research, 34 (7), 754–755.
   PubMed Web of Science ®Google Scholar
• Lakomy, D.S., et al., 2021. Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: A systematic review. Cancer Medicine, 10 (13), 4206–4220.
   PubMed Web of Science ®Google Scholar
• Mayadev, J.S., et al., 2022. Global challenges of radiotherapy for the treatment of locally advanced cervical cancer. International Journal of Gynecological Cancer, 32 (3), 436–445.
   PubMed Web of Science ®Google Scholar
• Miller, K.D., et al., 2022. Cancer treatment and survivorship statistics, 2022. CA: A Cancer Journal for Clinicians, 72 (5), 409–436.
   PubMed Web of Science ®Google Scholar
• Onal, C., et al., 2018. The utility of pretreatment and posttreatment lymphopenia in cervical squamous cell carcinoma patients treated with definitive chemoradiotherapy. International Journal of Gynecological Cancer, 28 (8), 1553–1559.
   PubMed Web of Science ®Google Scholar
• Page, M.J., et al., 2021a. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71.
   PubMed Web of Science ®Google Scholar
• Page, M.J., et al., 2021b. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ, 372, n160.
   PubMed Web of Science ®Google Scholar
• Patsopoulos, N.A., Evangelou, E. and Ioannidis, J.P., 2008. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. International Journal of Epidemiology, 37 (5), 1148–1157.
   PubMed Web of Science ®Google Scholar
• Schreiber, R.D., Old, L.J. and Smyth, M.J., 2011. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science, 331 (6024), 1565–1570.
   PubMed Web of Science ®Google Scholar
• Shi, F., et al., 2022. Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer. Obstetrics & Gynecology Science, 65 (2), 176–187.
   PubMedGoogle Scholar
• Taguchi, A., et al., 2020. Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study. International Journal of Clinical Oncology, 25 (5), 955–962.
   PubMed Web of Science ®Google Scholar
• Terrones-Campos, C., et al., 2019. Lymphocyte count kinetics, factors associated with the end-of-radiation-therapy lymphocyte count, and risk of infection in patients with solid malignant tumors treated with curative-intent radiation therapy. International Journal of Radiation Oncology, Biology, Physics, 105 (4), 812–823.
   PubMed Web of Science ®Google Scholar
• Venkatesulu, B.P., et al., 2018. A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors. Critical Reviews in Oncology/Hematology, 123, 42–51.
   PubMed Web of Science ®Google Scholar
• Vizzielli, G., et al., 2021. Is a vaginectomy enough or is a pelvic exenteration always required for surgical treatment of recurrent cervical cancer? a propensity-matched study. Annals of Surgical Oncology, 28 (6), 3281–3290.
   PubMed Web of Science ®Google Scholar
• Wells, G.A., et al., 2010. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
   Google Scholar
• Williamson, C.W., et al., 2022. Positron emission tomography-guided bone marrow-sparing radiation therapy for locoregionally advanced cervix cancer: final results from the INTERTECC Phase II/III trial. International Journal of Radiation Oncology, Biology, Physics, 112 (1), 169–178.
   PubMed Web of Science ®Google Scholar
• Wu, E.S., et al., 2016. Lymphopenia and its association with survival in patients with locally advanced cervical cancer. Gynecologic Oncology, 140 (1), 76–82.
   PubMed Web of Science ®Google Scholar
• Xu, Z., et al., 2022. A machine learning model for grade 4 lymphopenia prediction during pelvic radiotherapy in patients with cervical cancer. Frontiers in Oncology., 12, 905222.
   PubMedGoogle Scholar
• Yang, L., et al., 2022. Early onset of severe lymphopenia during definitive radiotherapy correlates with mean body dose and predicts poor survival in cervical cancer. Cancer Biomarkers: Section A of Disease Markers, 34 (1), 149–159.
   PubMed Web of Science ®Google Scholar